To dive deeper into how to build a sustainable, cost-effective weight management program, watch our complete webinar, The GLP-1 Breakthrough: What it is, Why it Matters, and How to Drive Health Plan Savings, or download the The ABCs of GLP-1s for Self-Funded Plans guide
An experimental drug from Lilly, eloralintide, led to an average 11.3% weight loss over 12 weeks in a Phase 1 study, according to new results published last week at the diabetes conference
The form below has it all
FFA and glycerol were quantified on the Cobas 6000 analyser in samples that were supplemented with sodium fluoride for stabilization
Our comprehensive service includes doctor consultations to monitor for and help manage any side effects you might experience, ensuring your comfort and safety